6533b873fe1ef96bd12d5229

RESEARCH PRODUCT

Can we ameliorate the compliance to intravesical bcg maintenance? Analysis of the causes of treatment interruption in 160 consecutive patients.

V AlongeF SommatinoC Scalici GesolfoS ScurriaF D’amatoF TorrettaMarco VellaVincenzo Serretta

subject

Bladder cancer BCG toxicitySettore MED/24 - Urologiahttp://hdl.handle.net/10447/85090